[Skip to Content]
[Skip to Content Landing]
Article
May 1966

CURRENT SITUATION ON USE OF DOW CORNING SILICONE FLUID FOR SOFT TISSUE AUGMENTATION BY INJECTION

Author Affiliations

Assistant Director Dow Corning Center for Aid to Medical Research

Arch Otolaryngol. 1966;83(5):508. doi:10.1001/archotol.1966.00760020510035
Abstract

To the Editor: As early as 1954, independent investigators reported on the use of dimethylpolysiloxane fluids, often referred to simply as silicone fluid, for soft tissue augmentation by injection techniques. Various reports in the literature and the lay press have described the use of pure silicone fluid or mixtures of silicone fluid and some other (usually secret) materials for mammary augmentation, treatment of facial hemiatrophy, wrinkle eradication, etc.

The Dow Corning Center for Aid to Medical Research has been concerned about the problems involved by the rather indiscriminate injection of silicone fluids to people throughout the world. The articles in the lay press which have appeared since early 1965 have not diminished these problems.

Silicones, alone or in combination with other materials, intended for injection into humans are considered as "new drugs" by the Federal Food and Drug Administration.1 At the present time any work involving silicone fluid

First Page Preview View Large
First page PDF preview
First page PDF preview
×